ALFA News
Straight from the exchange filing
Every announcement Godavari Biorefineries has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Godavari Biorefineries announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Godavari Biorefineries Ltd receives a US patent for a novel class of compounds targeting breast and prostate cancer, as trials for MSP008-22 start in Q3 FY27.
Godavari Biorefineries Ltd receives a Mexican patent for V-ATPase inhibiting compounds to treat viral infections. Term expires 2041. Market Cap: ₹1,162.62 Cr.
Godavari Biorefineries (GODAVARIB) receives a Chinese patent for antiviral compounds targeting V-ATPase activity, boosting its specialty biotech R&D portfolio.
